Quick Answer
STERIS plc reported Cash and Equivalents of $220.53 million for fiscal year 2021.
STERIS plc Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2021 | $220.53M | -31.0% |
| 2020 | $319.58M | +44.8% |
| 2019 | $220.63M | +9.5% |
| 2018 | $201.53M | -28.8% |
| 2017 | $282.92M | +13.7% |
| 2016 | $248.84M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $423.70M | +173.0% | +32.7% |
| September 30, 2025 | $319.20M | +85.4% | +14.1% |
| June 30, 2025 | $279.70M | +41.0% | +62.9% |
| March 31, 2025 | $171.70M | -17.1% | +10.6% |
| December 31, 2024 | $155.18M | -20.7% | -9.9% |
| September 30, 2024 | $172.19M | -19.4% | -13.2% |
| June 30, 2024 | $198.33M | -4.9% | -4.2% |
| March 31, 2024 | $207.02M | -0.6% | +5.8% |
- STERIS plc showed a decrease of -31.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2016–2021 period, STERIS plc’s cash and equivalents has declined by 11.4% (from $248.84 million to $220.53 million).
- The most recent figure is from STERIS plc’s fiscal year 2020 report (Form 10-K), filed with the SEC on May 28, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: